DVA HEALTHCARE RENAL CARE, INC.
NPI: 1265400501
· TALLAHASSEE, FL 32308
· 261QE0700X
$11.60M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
| 2018 |
26,909 |
$2.84M |
| 2019 |
23,151 |
$2.33M |
| 2020 |
29,879 |
$3.55M |
| 2021 |
20,789 |
$1.19M |
| 2022 |
10,325 |
$1.03M |
| 2023 |
7,220 |
$453K |
| 2024 |
3,143 |
$213K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
| 90999 |
|
35,616 |
2,344 |
$3.66M |
| Q4081 |
Epoetin alfa, 100 units esrd |
37,109 |
1,594 |
$2.91M |
| J1270 |
Injection, doxercalciferol |
23,363 |
1,389 |
$2.06M |
| A4657 |
Syringe w/wo needle |
5,460 |
1,704 |
$1.00M |
| J1756 |
Iron sucrose injection |
6,485 |
1,309 |
$552K |
| 83970 |
|
1,919 |
1,167 |
$193K |
| 82728 |
|
1,876 |
1,167 |
$190K |
| 83550 |
|
1,882 |
1,166 |
$185K |
| 83540 |
|
1,872 |
1,163 |
$185K |
| 85041 |
|
1,552 |
972 |
$156K |
| 85048 |
|
1,510 |
936 |
$153K |
| 85045 |
|
1,470 |
878 |
$148K |
| J0604 |
Cinacalcet, esrd on dialysis |
382 |
62 |
$104K |
| 82108 |
|
443 |
283 |
$49K |
| J0887 |
Epoetin beta esrd use |
177 |
73 |
$28K |
| G0499 |
Hepb screen high risk indiv |
263 |
98 |
$20K |
| J2405 |
Ondansetron hcl injection |
37 |
14 |
$8K |